Jason Wittes
Stock Analyst at Roth MKM
(3.19)
# 1,073
Out of 4,784 analysts
61
Total ratings
45.28%
Success rate
2.51%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $3.20 | +400.00% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $2.79 | +93.55% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.61 | +893.79% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $16.06 | +36.99% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $52.41 | +37.38% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.62 | +95.73% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $72.55 | +58.51% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $6.19 | +481.58% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $6.11 | +80.03% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $0.96 | +941.67% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $83.05 | +20.41% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $348 → $405 | $364.50 | +11.11% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.80 | +177.78% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.82 | +394.51% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $37.76 | +98.62% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $10.19 | +115.90% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $112.26 | +6.89% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $163.55 | +25.96% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $205.13 | -29.31% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $9.30 | +61.29% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $18.86 | +960.45% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $39.86 | -34.77% | 1 | Feb 22, 2017 |
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $3.20
Upside: +400.00%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $2.79
Upside: +93.55%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.61
Upside: +893.79%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $16.06
Upside: +36.99%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $52.41
Upside: +37.38%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.62
Upside: +95.73%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $72.55
Upside: +58.51%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $6.19
Upside: +481.58%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $6.11
Upside: +80.03%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $0.96
Upside: +941.67%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $83.05
Upside: +20.41%
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $364.50
Upside: +11.11%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $1.80
Upside: +177.78%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.82
Upside: +394.51%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $37.76
Upside: +98.62%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $10.19
Upside: +115.90%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $112.26
Upside: +6.89%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $163.55
Upside: +25.96%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $205.13
Upside: -29.31%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $9.30
Upside: +61.29%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $18.86
Upside: +960.45%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $39.86
Upside: -34.77%